Company Ophthotech Corp Nasdaq
Equities
US6837451037
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 30/06/13 |
Mark Reisenauer
PSD | President | 58 | 10/07/23 |
Xiao Ping Dai
CTO | Chief Tech/Sci/R&D Officer | - | - |
Keith Westby
COO | Chief Operating Officer | 49 | 28/01/17 |
Evelyn Harrison
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/07 |
Kathy Galante
IRC | Investor Relations Contact | - | 12/11/13 |
Corporate Officer/Principal | 49 | 01/08/21 | |
Julie Clark
PRN | Corporate Officer/Principal | - | - |
Amy Sheehan
HRO | Human Resources Officer | - | 31/12/13 |
Dhaval Desai
PRN | Corporate Officer/Principal | - | 31/12/19 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Sblendorio
CEO | Chief Executive Officer | 68 | 30/06/13 |
Mark Reisenauer
PSD | President | 58 | 10/07/23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 137,976,851 | 137,657,408 ( 99.77 %) | 0 | 99.77 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+0.67% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+6.55% | 24.63B | |
-21.66% | 18.2B | |
+29.96% | 12.01B | |
-1.57% | 11.76B | |
+16.03% | 10.4B | |
-4.80% | 9.94B |